BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11966861)

  • 1. Almotriptan reduces the incidence of migraine-associated symptoms: a pooled analysis.
    Cady R
    Headache; 2002 Jan; 42 Suppl 1():26-31. PubMed ID: 11966861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spotlight on almotriptan in migraine.
    Keam SJ; Goa KL; Figgitt DP
    CNS Drugs; 2002; 16(7):501-7. PubMed ID: 12056924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Almotriptan: a review of its use in migraine.
    Keam SJ; Goa KL; Figgitt DP
    Drugs; 2002; 62(2):387-414. PubMed ID: 11817980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of almotriptan in adolescents: a randomized, double-blind, placebo-controlled trial.
    Linder SL; Mathew NT; Cady RK; Finlayson G; Ishkanian G; Lewis DW
    Headache; 2008 Oct; 48(9):1326-36. PubMed ID: 18484981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Almotriptan increases pain-free status in patients with acute migraine treated in placebo-controlled clinical trials.
    Mathew NT
    Headache; 2002 Jan; 42 Suppl 1():32-7. PubMed ID: 11966862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin with or without an antiemetic for acute migraine headaches in adults.
    Kirthi V; Derry S; Moore RA; McQuay HJ
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008041. PubMed ID: 20393963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral almotriptan in the treatment of migraine: safety and tolerability.
    Dodick DW
    Headache; 2001 May; 41(5):449-55. PubMed ID: 11380642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early intervention with almotriptan: results of the AEGIS trial (AXERT Early Migraine Intervention Study).
    Mathew NT; Finlayson G; Smith TR; Cady RK; Adelman J; Mao L; Wright P; Greenberg SJ;
    Headache; 2007 Feb; 47(2):189-98. PubMed ID: 17300358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Almotriptan is an effective and well-tolerated treatment for migraine pain: results of a randomized, double-blind, placebo-controlled clinical trial.
    Dowson AJ; Massiou H; LaĆ­nez JM; Cabarrocas X
    Cephalalgia; 2002 Jul; 22(6):453-61. PubMed ID: 12133045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Almotriptan improves response rates when treatment is within 1 hour of migraine onset.
    Dowson AJ; Massiou H; Lainez JM; Cabarrocas X
    Headache; 2004 Apr; 44(4):318-22. PubMed ID: 15109355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
    Winner P; Landy S; Richardson M; Ames M
    Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine.
    Nett R; Landy S; Shackelford S; Richardson MS; Ames M; Lener M
    Obstet Gynecol; 2003 Oct; 102(4):835-42. PubMed ID: 14551015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute treatment of migraine attacks: efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac-potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group.
    Cephalalgia; 1999 May; 19(4):232-40. PubMed ID: 10376168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies.
    Ryan R; Elkind A; Baker CC; Mullican W; DeBussey S; Asgharnejad M
    Neurology; 1997 Nov; 49(5):1225-30. PubMed ID: 9371898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diclofenac with or without an antiemetic for acute migraine headaches in adults.
    Derry S; Rabbie R; Moore RA
    Cochrane Database Syst Rev; 2012 Feb; 2(2):CD008783. PubMed ID: 22336852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison.
    Spierings EL; Gomez-Mancilla B; Grosz DE; Rowland CR; Whaley FS; Jirgens KJ
    Arch Neurol; 2001 Jun; 58(6):944-50. PubMed ID: 11405809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
    Lipton RB; Pascual J; Goadsby PJ; Massiou H; McCarroll KA; Vandormael K; Jiang K; Lines CR
    Headache; 2001 Sep; 41(8):754-63. PubMed ID: 11576198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2007 Sep; 47(8):1169-77. PubMed ID: 17883521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Almotriptan increases sustained pain-free outcomes in acute migraine: results from three controlled clinical trials.
    Dodick DW
    Headache; 2002 Jan; 42(1):21-7. PubMed ID: 12005271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.